nach oben

Current Rheumatology Reports

Erschienen in:

12.01.2024

Twenty Years of SPARTAN: From Inception to Impact (SPARTAN 2023 Annual Meeting Proceedings)

verfasst von: Joerg Ermann, Atul Deodhar, Muhammad Asim Khan, Michael H. Weisman, John D. Reveille

Erschienen in: Current Rheumatology Reports | Ausgabe 3/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

This review takes a look at the past, present, and future of SPARTAN, the Spondyloarthritis Research and Treatment Network, an organization of North American healthcare professionals dedicated to advancing research, education, and patient care in spondyloarthritis.

Recent Findings

In 2022, SPARTAN completed the Classification of Axial SpondyloarthritiS Inception Cohort (CLASSIC) study, a collaboration with the Assessment in SpondyloArthritis International Society (ASAS). CLASSIC aimed to validate the 2009 ASAS classification criteria for axial spondyloarthritis. Other ongoing SPARTAN endeavors include the development of US referral recommendations for axial spondyloarthritis, an update of the 2019 ACR/SAA/SPARTAN treatment recommendations for axial spondyloarthritis and multiple educational initiatives.

Summary

Twenty years after its inception, SPARTAN continues to grow and broaden its impact, guided by the SPARTAN vision of “a world free of spondyloarthritis through leadership in research and education.”

Braun J, Pham T, Sieper J, Davis J, van der Linden S, Dougados M, et al. International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis. Ann Rheum Dis. 2003;62(9):817–24. https://doi.org/10.1136/ard.62.9.817.CrossRefPubMedCentralPubMed

Khan MA, Clegg DO, Deodhar AA, Gabriel S, Gaston JS, Hirsch R, et al. 2006 annual research and education meeting of the Spondyloarthritis Research and Therapy Network (SPARTAN). J Rheumatol. 2007;34(5):1118–24.PubMed

Reveille JD, Witter JP, Weisman MH. Prevalence of axial spondylarthritis in the United States: estimates from a cross-sectional survey. Arthritis Care Res (Hoboken). 2012;64(6):905–10. https://doi.org/10.1002/acr.21621.CrossRefPubMedCentralPubMed

Reveille JD, Hirsch R, Dillon CF, Carroll MD, Weisman MH. The prevalence of HLA-B27 in the US: data from the US National Health and Nutrition Examination Survey, 2009. Arthritis Rheum. 2012;64(5):1407–11. https://doi.org/10.1002/art.33503.CrossRefPubMedCentralPubMed

Johnson SR, Turner AS, Goodman SM. How the American College of Rheumatology develops guidelines. Rheum Dis Clin North Am. 2022;48(3):579–88. https://doi.org/10.1016/j.rdc.2022.04.001.CrossRefPubMed

Caplan AM, Caplan L. The GRADE method. Rheum Dis Clin North Am. 2022;48(3):589–99. https://doi.org/10.1016/j.rdc.2022.04.002.CrossRefPubMed

Ward MM, Deodhar A, Akl EA, Lui A, Ermann J, Gensler LS, et al. American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis Rheumatol. 2016;68(2):282–98. https://doi.org/10.1002/art.39298.CrossRefPubMed

Ward MM, Deodhar A, Gensler LS, Dubreuil M, Yu D, Khan MA, et al. 2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis Rheumatol. 2019;71(10):1599–613. https://doi.org/10.1002/art.41042.CrossRefPubMedCentralPubMed

Rudwaleit M, van der Heijde D, Landewe R, Listing J, Akkoc N, Brandt J, et al. The development of Assessment of SpondyloArthritis International Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009;68(6):777–83. https://doi.org/10.1136/ard.2009.108233.CrossRefPubMed

10.

Khan MA, van der Linden SM, Kushner I, Valkenburg HA, Cats A. Spondylitic disease without radiologic evidence of sacroiliitis in relatives of HLA-B27 positive ankylosing spondylitis patients. Arthritis Rheum. 1985;28(1):40–3. https://doi.org/10.1002/art.1780280107.CrossRefPubMed

11.

Deodhar A, Reveille JD, van den Bosch F, Braun J, Burgos-Vargas R, Caplan L, et al. The concept of axial spondyloarthritis: joint statement of the spondyloarthritis research and treatment network and the Assessment of SpondyloArthritis international Society in response to the US Food and Drug Administration's comments and concerns. Arthritis Rheumatol. 2014;66(10):2649–56. https://doi.org/10.1002/art.38776.CrossRefPubMed

12.

Ward MM, Bruckel J, Colbert R, Deodhar A, Emerson C, Genant H, et al. Summary of the 2005 annual research and education meeting of the Spondyloarthritis Research and Therapy Network (SPARTAN). J Rheumatol. 2006;33(5):978–82.PubMed

13.

Colbert RA, Deodhar AA, Khan MA, Lories RJ, Maksymowych WP, Reveille JD, et al. 2007 annual research and education meeting of the Spondyloarthritis Research and Therapy Network (SPARTAN). J Rheumatol. 2008;35(7):1398–402.PubMed

14.

Colbert RA, Deodhar AA, Fox D, Gravallese EM, Khan MA, McGonagle D, et al. Entheses and bones in spondyloarthritis: 2008 annual research and education meeting of the Spondyloarthritis Research and Therapy Network (SPARTAN). J Rheumatol. 2009;36(7):1527–31. https://doi.org/10.3899/jrheum.090122.CrossRefPubMedCentralPubMed

15.

Reveille JD, Clegg DO. Prologue: 2009 joint meeting of Spondyloarthritis Research and Therapy Network (SPARTAN) and International Genetics of Ankylosing Spondylitis (IGAS). J Rheumatol. 2010;37(12):2604–5. https://doi.org/10.3899/jrheum.100888.CrossRefPubMed

16.

Espinoza LR, Reveille JD, Clegg DO. Prologue: 2010 Spondyloarthritis Research and Therapy Network (SPARTAN) annual research and education meeting. Am J Med Sci. 2011;341(4):266–8. https://doi.org/10.1097/MAJ.0b013e31820f8b13.CrossRefPubMed

17.

Espinoza LR. Introduction to the eleventh Spondyloarthritis Research and Therapy Network (SPARTAN) annual research and education meeting. Clin Rheumatol. 2014;33(6):737–8. https://doi.org/10.1007/s10067-014-2659-2.CrossRefPubMed

18.

Espinoza LR. SPARTAN annual meeting, New York City 2014. Clin Rheumatol. 2015;34(6):985–6. https://doi.org/10.1007/s10067-015-2957-3.CrossRefPubMed

19.

Espinoza LR. Spartan annual meeting: Denver, Colorado. Clin Rheumatol. 2016;35(6):1413–4. https://doi.org/10.1007/s10067-016-3260-7.CrossRefPubMed

Titel: Twenty Years of SPARTAN: From Inception to Impact (SPARTAN 2023 Annual Meeting Proceedings)
verfasst von: Joerg Ermann
Atul Deodhar
Muhammad Asim Khan
Michael H. Weisman
John D. Reveille
Publikationsdatum: 12.01.2024
Verlag: Springer US
Erschienen in: Current Rheumatology Reports / Ausgabe 3/2024
Print ISSN: 1523-3774
Elektronische ISSN: 1534-6307
DOI: https://doi.org/10.1007/s11926-023-01131-8

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Twenty Years of SPARTAN: From Inception to Impact (SPARTAN 2023 Annual Meeting Proceedings)

Abstract

Purpose of Review

Recent Findings

Summary

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Blutdrucksenkung könnte Uterusmyome verhindern

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

Update Innere Medizin

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Blutdrucksenkung könnte Uterusmyome verhindern

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

Update Innere Medizin